Lianyungang, China

Zupeng Xu

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zupeng Xu: Innovator in Medical Antibody Development

Introduction

Zupeng Xu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of medical science, particularly in the development of antibodies for treating allergic diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical treatments.

Latest Patents

Zupeng Xu holds a patent for a "Human IL-4R binding antibody, antigen binding fragment thereof, and medical use thereof." This patent describes a human IL-4R binding antibody and its antigen binding fragments, which are crucial for developing pharmaceutical compositions aimed at treating allergic diseases. The patent also includes a chimeric antibody and a humanized antibody that incorporates a CDR region from a human IL-4R binding antibody. This work highlights the potential of his inventions in addressing IL-4R mediated diseases.

Career Highlights

Throughout his career, Zupeng Xu has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in antibody development and medical applications.

Collaborations

Zupeng Xu has collaborated with notable professionals in his field, including Cheng Liao and Jiahua Jiang. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in medical science.

Conclusion

Zupeng Xu's contributions to the field of medical antibodies demonstrate his commitment to innovation and improving healthcare. His patent for the human IL-4R binding antibody is a testament to his expertise and the potential impact of his work on treating allergic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…